<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02542150</url>
  </required_header>
  <id_info>
    <org_study_id>15-0933</org_study_id>
    <secondary_id>UL1TR001082</secondary_id>
    <nct_id>NCT02542150</nct_id>
  </id_info>
  <brief_title>Effects of Acetate and Alcohol on Brain Function</brief_title>
  <official_title>Effects of Acetate and Alcohol on Brain Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to learn more about how alcohol and its metabolite, acetate, affect the&#xD;
      brain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study plans to learn more about how alcohol and its metabolite, acetate, affect brain&#xD;
      function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">March 31, 2017</completion_date>
  <primary_completion_date type="Actual">March 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Cerebral Blood Flow as Measured With Arterial Spin Labeling</measure>
    <time_frame>fMRI scan will be scheduled for 1-3 weeks after enrollment. Total visit will be about 6 hrs.</time_frame>
    <description>cerebral blood flow is measured during a functional magnetic resonance imaging (fMRI). The reported data reflects best efforts to quantify the collected image data.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Cerebral Blood Flow</condition>
  <condition>Brain Function</condition>
  <arm_group>
    <arm_group_label>acetate arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IV acetate given during magnetic resonance scan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alcohol arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>jello shots given before magnetic resonance scan</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>acetate</intervention_name>
    <description>acetate infusion, saline infusion, functional magnetic resonance imaging (fMRI) scan</description>
    <arm_group_label>acetate arm</arm_group_label>
    <other_name>ethanoate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>alcohol</intervention_name>
    <description>a &quot;jello shot&quot; containing alcohol, a jello shot containing no alcohol, fMRI scan.</description>
    <arm_group_label>alcohol arm</arm_group_label>
    <other_name>ethanol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria-all:&#xD;
&#xD;
          1. Subjects who are age 21-55,&#xD;
&#xD;
          2. Subjects who are proficient in English ,&#xD;
&#xD;
          3. Subjects who understand the nature of the study,&#xD;
&#xD;
          4. Subjects who have signed an informed consent,&#xD;
&#xD;
          5. Subjects who are non-smoking (defined as fewer than 20 cigarettes lifetime),&#xD;
&#xD;
        Inclusion Criteria-moderate drinkers:&#xD;
&#xD;
          1. Subjects who are moderate drinkers (male:1-14 drinks per week; female: 1-7 drinks per&#xD;
             week).&#xD;
&#xD;
          2. Subjects who have drunk at least 2 drinks in one hour in the past, and have no history&#xD;
             of dependence on drugs or alcohol&#xD;
&#xD;
        Inclusions-AUD:&#xD;
&#xD;
        (1) Subjects who meet DSM-V criteria for lifetime history of Alcohol Use Disorder (AUD)&#xD;
&#xD;
        Exclusion Criteria-all:&#xD;
&#xD;
          1. Subjects who have a &quot;facial flushing&quot; response to alcohol,&#xD;
&#xD;
          2. Subjects who are pregnant or nursing,&#xD;
&#xD;
          3. Subjects who have major medical problems including diabetes, high blood pressure (&gt;&#xD;
             150/90), prior neurological or psychiatric history (schizophrenia, bipolar, or current&#xD;
             major depressive disorder), epilepsy (alcohol withdrawal seizures is not an&#xD;
             exclusion),&#xD;
&#xD;
          4. Subjects who have been told they have or been diagnosed with liver or kidney disease,&#xD;
&#xD;
          5. Subjects who have chronic gastrointestinal disease,&#xD;
&#xD;
          6. Subjects who are obese (BMI&gt;30 kg/m2),&#xD;
&#xD;
          7. Subjects who take psychoactive medications,&#xD;
&#xD;
          8. Subjects who have prior head trauma resulting in loss of consciousness &gt;15 minutes,&#xD;
&#xD;
          9. Subjects who have Magnetic Resonance (MR) exclusions which include claustrophobia,&#xD;
             intracranial, orbital, or spinal metal implants, pacemakers, cochlear implants,&#xD;
             cardiac stents or other non-MR-compatible implants or devices.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jody L Tanabe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Tanabe J, Yamamoto DJ, Sutton B, Brown MS, Hoffman PL, Burnham EL, Glueck DH, Tabakoff B. Effects of Alcohol and Acetate on Cerebral Blood Flow: A Pilot Study. Alcohol Clin Exp Res. 2019 Oct;43(10):2070-2078. doi: 10.1111/acer.14173. Epub 2019 Aug 24.</citation>
    <PMID>31386214</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>September 1, 2015</study_first_submitted>
  <study_first_submitted_qc>September 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2015</study_first_posted>
  <results_first_submitted>June 2, 2021</results_first_submitted>
  <results_first_submitted_qc>June 2, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">June 25, 2021</results_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 22, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/50/NCT02542150/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Dates: January 2016-March 2017 Target population: Healthy controls Method: Advertisements, flyers, word of mouth</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Acetate Arm</title>
          <description>Placebo for 1 hour, then Acetate for 1 hour&#xD;
IV acetate given during magnetic resonance scan.&#xD;
acetate: acetate infusion, saline infusion, functional magnetic resonance imaging (fMRI) scan</description>
        </group>
        <group group_id="P2">
          <title>Alcohol Arm</title>
          <description>Placebo for 1 hour, then Alcohol (given as a single dose of jello).&#xD;
jello given before magnetic resonance scan&#xD;
alcohol: jello containing alcohol, jello containing no alcohol, fMRI scan.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed Placebo</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Started Intervention</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acetate Arm</title>
          <description>Placebo for 1 hour, then Acetate for 1 hour.&#xD;
IV acetate given during magnetic resonance scan&#xD;
acetate: acetate infusion, saline infusion, functional magnetic resonance imaging (fMRI) scan</description>
        </group>
        <group group_id="B2">
          <title>Alcohol Arm</title>
          <description>Placebo for 1 hour, then alcohol (given as a single dose with jello).&#xD;
jello given before magnetic resonance scan&#xD;
alcohol: jello containing alcohol, jello containing no alcohol, fMRI scan.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="24"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.8" spread="4.2"/>
                    <measurement group_id="B2" value="31.1" spread="3.9"/>
                    <measurement group_id="B3" value="28.5" spread="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Cerebral Blood Flow as Measured With Arterial Spin Labeling</title>
        <description>cerebral blood flow is measured during a functional magnetic resonance imaging (fMRI). The reported data reflects best efforts to quantify the collected image data.</description>
        <time_frame>fMRI scan will be scheduled for 1-3 weeks after enrollment. Total visit will be about 6 hrs.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetate Arm</title>
            <description>IV acetate given during magnetic resonance scan&#xD;
acetate: acetate infusion, saline infusion, functional magnetic resonance imaging (fMRI) scan</description>
          </group>
          <group group_id="O2">
            <title>IV Placebo (Acetate Arm)</title>
            <description>Placebo given before Acetate.</description>
          </group>
          <group group_id="O3">
            <title>Alcohol Arm</title>
            <description>jello shots given before magnetic resonance scan&#xD;
alcohol: a &quot;jello shot&quot; containing alcohol, a jello shot containing no alcohol, fMRI scan.</description>
          </group>
          <group group_id="O4">
            <title>Oral Placebo (Alcohol Arm)</title>
            <description>Placebo given before Alcohol.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cerebral Blood Flow as Measured With Arterial Spin Labeling</title>
          <description>cerebral blood flow is measured during a functional magnetic resonance imaging (fMRI). The reported data reflects best efforts to quantify the collected image data.</description>
          <units>cc/100 mg/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Right Thalamus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.7" spread="5.6"/>
                    <measurement group_id="O2" value="26.9" spread="5.7"/>
                    <measurement group_id="O3" value="30.0" spread="9.7"/>
                    <measurement group_id="O4" value="25.0" spread="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Left Thalamus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.8" spread="6.8"/>
                    <measurement group_id="O2" value="27.3" spread="5.6"/>
                    <measurement group_id="O3" value="29.9" spread="8.9"/>
                    <measurement group_id="O4" value="24.9" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 Day</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acetate Arm</title>
          <description>IV acetate given during magnetic resonance scan&#xD;
acetate: acetate infusion, saline infusion, functional magnetic resonance imaging (fMRI) scan</description>
        </group>
        <group group_id="E2">
          <title>IV Placebo (Acetate Arm)</title>
          <description>Placebo given before Acetate.</description>
        </group>
        <group group_id="E3">
          <title>Alcohol Arm</title>
          <description>jello given before magnetic resonance scan&#xD;
alcohol: jello containing alcohol, jello containing no alcohol, fMRI scan.</description>
        </group>
        <group group_id="E4">
          <title>Oral Placebo (Alcohol Arm)</title>
          <description>Placebo given before Alcohol.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="12"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Data collection for an outcome measure related to brain activity during decision making before and after receiving alcohol or acetate was never completed due to feasibility and funding limitations and challenges encountered during the study.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jody Tanabe, MD</name_or_title>
      <organization>University of Colorado Denver | Anschutz</organization>
      <phone>3037241111</phone>
      <email>clinicalresearchsupportcenter@ucdenver.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

